Hemogenyx Pharmaceuticals PLC (HEMO) — Cash Flow Reinvestment Rate

Latest as of June 2017: 0.47x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Reinvestment Rate of 0.47x as of June 2017, reinvesting GBX11.02 (capex GBX11.02 ) from operating cash flow of GBX23.26. See cash generation quality of Hemogenyx Pharmaceuticals PLC to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.47x
(Capex + Investments) / Operating CF

Total Reinvested

GBX11.02
Capex + Investments

Operating Cash Flow

GBX23.26
GBX

Capital Expenditures

GBX11.02
GBX

Hemogenyx Pharmaceuticals PLC Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Hemogenyx Pharmaceuticals PLC across 1 annual periods. For the full cash flow conversion analysis, see HEMO operating cash flow.

Annual Cash Flow Reinvestment Rate for Hemogenyx Pharmaceuticals PLC (2015–2015)

Year-by-year capital reinvestment analysis for Hemogenyx Pharmaceuticals PLC. See Hemogenyx Pharmaceuticals PLC (HEMO) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (GBX) Operating CF Capex YoY Change
2015 0.00x GBX0.00 GBX79.71 GBX0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow